Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Oral Anticoagulant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02219984
What this trial is testing

START-Register: Survey on Anticoagulated Patients Register

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
GUALTIERO PALARETI 15,410
Not applicableUnknownNCT04684056
What this trial is testing

Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

Who this might be right for
Oral AnticoagulantAtrial FibrillationPharmacokinetics and Pharmacodynamics
Wuhan Asia Heart Hospital 1,864
Post-approval studies (Phase 4)Looking for participantsNCT05955365
What this trial is testing

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Who this might be right for
Percutaneous Coronary Intervention (PCI)Atrial Fibrillation (AF)Oral Anticoagulation+1 more
Insel Gruppe AG, University Hospital Bern 3,010
Not applicableStudy completedNCT04394234
What this trial is testing

Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants

Who this might be right for
Uterine Hemorrhage
Janssen Research & Development, LLC 961,985
Not applicableLooking for participantsNCT06947707
What this trial is testing

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Who this might be right for
Cerebral Venous ThrombosisAnticoagulants and Thrombotic DisordersAnticoagulation Treatment+6 more
Xuanwu Hospital, Beijing 1,486
Not applicableEnded earlyNCT04247919
What this trial is testing

DOAC ADRs Retrospective Study

Who this might be right for
Drug-Related Side Effects and Adverse Reactions
Cipherome, Inc. 3
Not applicableStudy completedNCT02833987
What this trial is testing

Direct Oral Anticoagulants and Venous Thromboembolism

Who this might be right for
Venous ThromboembolismMajor Bleed
Canadian Network for Observational Drug Effect Studies, CNODES 59,525
Not applicableNot Yet RecruitingNCT05764356
What this trial is testing

Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II

Who this might be right for
Novel Oral AnticoagulantsNOACsRivaroxaban+9 more
Peking University First Hospital 2,000
Not applicableStudy completedNCT06239402
What this trial is testing

Therapeutic Strategy with Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart Disease

Who this might be right for
Atrial Fibrillation
Istituti Clinici Scientifici Maugeri SpA 394
Not applicableStudy completedNCT03189069
What this trial is testing

A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 36,000
Not applicableEnded earlyNCT02964546
What this trial is testing

Glomerular Filtration Rate-Estimating Equations During Use of Direct Oral Anticoagulants in Elderly Patients

Who this might be right for
Atrial FibrillationElderly PatientsChronic Kidney Disease
University Hospital, Montpellier 116
Not applicableLooking for participantsNCT05333666
What this trial is testing

The Association Between Non-vitamin K Antagonist Oral Anticoagulant Concentration and Clinical Outcomes.

Who this might be right for
Atrial Fibrillation
National Taiwan University Hospital 1,500
Not applicableStudy completedNCT03187197
What this trial is testing

Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,315
Not applicableLooking for participantsNCT06954610
What this trial is testing

Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation

Who this might be right for
Ischemic StrokeAtrial FibrillationCerebrovascular Disorders+11 more
Insel Gruppe AG, University Hospital Bern 500
Not applicableLooking for participantsNCT07270263
What this trial is testing

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more
Medical University of Gdansk 100
Not applicableUnknownNCT03887806
What this trial is testing

Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study

Who this might be right for
Venous Thromboembolic Disease
University Hospital, Strasbourg, France 300
Not applicableStudy completedNCT03568916
What this trial is testing

Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)

Who this might be right for
Atrial FibrillationIschemic StrokeSystemic Embolization+3 more
Canadian Network for Observational Drug Effect Studies, CNODES 227,579
Not applicableStudy completedNCT03803579
What this trial is testing

Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS)

Who this might be right for
Atrial FibrillationAnticoagulant-induced Bleeding
Arianna Anticoagulazione Foundation 2,000
Early research (Phase 1)Looking for participantsNCT04874428
What this trial is testing

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Insel Gruppe AG, University Hospital Bern 24
Not applicableActive Not RecruitingNCT06971081
What this trial is testing

LED Application Following Dental Extraction in Patients Taking Direct Oral Anticoagulants.

Who this might be right for
Direct Oral Anticoagulants (DOACs)
University College, London 50
Next Page